These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 1388220

  • 1. Secretory endometrial protein PP14 in serum from post-menopausal women receiving continuous combined oestradiol-cyproterone acetate: correlation with serum hormone concentrations and bleeding patterns.
    Byrjalsen I, Thormann L, Riis BJ, Christiansen C.
    Maturitas; 1992 Aug; 15(1):39-46. PubMed ID: 1388220
    [Abstract] [Full Text] [Related]

  • 2. Serum placental protein 14 (PP14) reflects endometrial status during hormone replacement therapy.
    Byrjalsen I, Thormann L, Meinecke B, Riis BJ, Christiansen C.
    Hum Reprod; 1992 Sep; 7(8):1042-7. PubMed ID: 1400926
    [Abstract] [Full Text] [Related]

  • 3. Serum placental protein 14 in pre-menopausal and post-menopausal women--dependency on oestrogen/progestogen status.
    Byrjalsen I, Riis BJ, Christiansen C.
    Maturitas; 1990 Jun; 12(2):79-88. PubMed ID: 2255265
    [Abstract] [Full Text] [Related]

  • 4. A prospective randomized controlled study comparing the morphological and biochemical responses of the endometrium to two different forms of 'period-free' hormone replacement therapy.
    Okon MA, Lee S, Laird SM, Li TC.
    Hum Reprod; 1998 Aug; 13(8):2261-5. PubMed ID: 9756307
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The post-menopausal uterus: the effect of hormone replacement therapy on the serum levels of secretory endometrial protein PP14/beta-lactoglobulin homologue.
    Seppälä M, Alfthan H, Vartiainen E, Stenman UH.
    Hum Reprod; 1987 Nov; 2(8):741-3. PubMed ID: 2830296
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Serum lipids, lipoproteins, and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxyprogesterone derivatives.
    Haarbo J, Hassager C, Jensen SB, Riis BJ, Christiansen C.
    Am J Med; 1991 May; 90(5):584-9. PubMed ID: 1827568
    [Abstract] [Full Text] [Related]

  • 9. Hormone replacement therapy: lipid responses to continuous combined oestrogen and progestogen versus oestrogen monotherapy.
    Metka M, Hanes V, Heytmanek G.
    Maturitas; 1992 Aug; 15(1):53-9. PubMed ID: 1326708
    [Abstract] [Full Text] [Related]

  • 10. Serum concentrations of two endometrial proteins are not useful for monitoring postmenopausal estrogen/progesterone therapy.
    Ren SG, Braunstein GD, Cedars M, Gambone J, Judd H.
    Fertil Steril; 1990 Sep; 54(3):532-4. PubMed ID: 1697814
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Sequential estrogen and progestogen therapy: assessment of progestational effects on the postmenopausal endometrium.
    Byrjalsen I, Thormann L, Meinecke B, Riis BJ, Christiansen C.
    Obstet Gynecol; 1992 Apr; 79(4):523-8. PubMed ID: 1532445
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Placental protein 14 (PP14) does not predict endometrial status under hormone replacement therapy.
    Haenggi W, Bersinger NA, Altermatt HJ, Birkhaeuser MH.
    Gynecol Endocrinol; 1997 Feb; 11(1):51-7. PubMed ID: 9086340
    [Abstract] [Full Text] [Related]

  • 15. Circulating concentrations of placenta protein 14 during the natural menstrual cycle in women significantly reflect endometrial receptivity to implantation and pregnancy during successive assisted reproduction cycles.
    Westergaard LG, Wiberg N, Andersen CY, Laursen SB, Kliem A, Westergaard JG, Teisner B.
    Hum Reprod; 1998 Sep; 13(9):2612-9. PubMed ID: 9806294
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
    Raudaskoski TH, Lahti EI, Kauppila AJ, Apaja-Sarkkinen MA, Laatikainen TJ.
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
    [Abstract] [Full Text] [Related]

  • 20. Secretory endometrial protein PP14 in women with early pregnancy bleeding.
    Ruge S, Sørensen S, Pedersen JF, Lange AP, Byrjalsen I, Bohn H.
    Hum Reprod; 1991 Jul; 6(6):885-8. PubMed ID: 1757530
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.